First Manhattan’s Anixa Biosciences ANIX Stock Holding History

First Manhattan’s Portfolio ANIX Stock Details ANIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-6,500	Closed	-$27.6K	–	1530
2022 Q4	$27.6K	Hold	6,500	–	–	﹤0.01%	1041
2022 Q3	$31K	Hold	6,500	–	–	﹤0.01%	1010
2022 Q2	$19K	Hold	6,500	–	–	﹤0.01%	1114
2022 Q1	$17K	Hold	6,500	–	–	﹤0.01%	1185
2021 Q4	$19K	Hold	6,500	–	–	﹤0.01%	1174
2021 Q3	$31K	Hold	6,500	–	–	﹤0.01%	1078
2021 Q2	$25K	Hold	6,500	–	–	﹤0.01%	1116
2021 Q1	$30K	Buy	+6,500	New	+$31.1K	﹤0.01%	1062
2019 Q4	–	Sell	-200	Closed	–	–	1292
2019 Q3	$0	Hold	200	–	–	﹤0.01%	1317
2019 Q2	$0	Hold	200	–	–	﹤0.01%	1361
2019 Q1	$0	Hold	200	–	–	﹤0.01%	1382
2018 Q4	$0	Hold	200	–	–	﹤0.01%	1357
2018 Q3	$0	Hold	200	–	–	﹤0.01%	1387
2018 Q2	$0	Hold	200	–	–	﹤0.01%	1345
2018 Q1	$0	Hold	200	–	–	﹤0.01%	1369
2017 Q4	$0	Hold	200	–	–	﹤0.01%	1439
2017 Q3	$0	Hold	200	–	–	﹤0.01%	1422
2017 Q2	$0	Hold	200	–	–	﹤0.01%	1386
2017 Q1	$0	Hold	200	–	–	﹤0.01%	1382
2016 Q4	$1K	Sell	200 -2,400	-92%	-$13.3K	﹤0.01%	1325
2016 Q3	$10K	Hold	2,600	–	–	﹤0.01%	1180
2016 Q2	$8K	Hold	2,600	–	–	﹤0.01%	1253
2016 Q1	$7K	Hold	2,600	–	–	﹤0.01%	1204
2015 Q4	$7K	Hold	2,600	–	–	﹤0.01%	1219
2015 Q3	$12K	Buy	+2,600	New	+$12.1K	﹤0.01%	1154

Other funds holding ANIX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

First Manhattan's ANIX Position: Q1 2023 in Review

First Manhattan sold out of Anixa Biosciences (ANIX) in Q1 2023, closing a stake of 6,500 shares — an estimated $27.6K sold.

First Manhattan first reported a position in ANIX in Q3 2015 and held it in 25 quarters. The position peaked at $31K in Q3 2022. 44 funds tracked by Wall St. Rank hold ANIX as of Q1 2023.

First Manhattan reported no remaining Anixa Biosciences position as of Q1 2023 after selling out during the quarter.
First Manhattan sold 6,500 Anixa Biosciences shares in Q1 2023, an estimated $27.6K.
First Manhattan first reported a position in Anixa Biosciences in Q3 2015 and held it in 25 quarters.
First Manhattan's Anixa Biosciences position peaked at $31K in Q3 2022.
44 funds tracked by Wall St. Rank held Anixa Biosciences as of Q1 2023.

Based on First Manhattan's 13F filing for Q1 2023, filed 15 May 2023.